Proteomics Applications in Toxoplasma gondii: Unveiling the Host–Parasite Interactions and Therapeutic Target Discovery
Pathogens · 2023
DOI: 10.3390/pathogens13010033 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pathogens, 2023. Verfasst von Bin Deng und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology and VBRN Proteomics Facility, University of Vermont, Burlington, VT 05405, USA. Hauptthemen laut MEDLINE: Toxoplasma, Proteomics, Host-Parasite Interactions, Toxoplasmosis. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 190 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, NIH HHS, NIH.
Abstract (Originalsprache)
Toxoplasma gondii, a protozoan parasite with the ability to infect various warm-blooded vertebrates, including humans, is the causative agent of toxoplasmosis. This infection poses significant risks, leading to severe complications in immunocompromised individuals and potentially affecting the fetus through congenital transmission. A comprehensive understanding of the intricate molecular interactions between T. gondii and its host is pivotal for the development of effective therapeutic strategies. This review emphasizes the crucial role of proteomics in T. gondii research, with a specific focus on host–parasite interactions, post-translational modifications (PTMs), PTM crosstalk, and ongoing efforts in drug discovery. Additionally, we provide an overview of recent advancements in proteomics techniques, encompassing interactome sample preparation methods such as BioID (BirA*-mediated proximity-dependent biotin identification), APEX (ascorbate peroxidase-mediated proximity labeling), and Y2H (yeast two hybrid), as well as various proteomics approaches, including single-cell analysis, DIA (data-independent acquisition), targeted, top-down, and plasma proteomics. Furthermore, we discuss bioinformatics and the integration of proteomics with other omics technologies, highlighting its potential in unraveling the intricate mechanisms of T. gondii pathogenesis and identifying novel therapeutic targets.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biology and VBRN Proteomics Facility, University of Vermont, Burlington, VT 05405, USA.
- Laboratorio de Parasitología Molecular, Instituto Tecnológico de Chascomús (CONICET-UNSAM), Chascomús 7130, Provincia de Buenos Aires, Argentina.
- Escuela de Bio y Nanotecnologías (UNSAM), 25 de Mayo y Francia. C.P., San Martín 1650, Provincia de Buenos Aires, Argentina.
ORCID-Profile: Bin Deng, Andres M Alonso, Sergio O Angel
Förderung
- NIGMS NIH HHS
- NIH HHS
- NIH
- ANPCyT
- CONICET
Zitieren
APA
Deng, B., Vanagas, L., Alonso, A. M., & Angel, S. O. (2023). Proteomics Applications in Toxoplasma gondii: Unveiling the Host–Parasite Interactions and Therapeutic Target Discovery. Pathogens. https://doi.org/10.3390/pathogens13010033
Vancouver
Deng B, Vanagas L, Alonso AM, Angel SO. Proteomics Applications in Toxoplasma gondii: Unveiling the Host–Parasite Interactions and Therapeutic Target Discovery. Pathogens. 2023. doi:10.3390/pathogens13010033
BibTeX
@article{Deng2023,
author = {Deng, Bin and Vanagas, Laura and Alonso, Andres M and Angel, Sergio O},
title = {Proteomics Applications in Toxoplasma gondii: Unveiling the Host–Parasite Interactions and Therapeutic Target Discovery},
journal = {Pathogens},
year = {2023},
doi = {10.3390/pathogens13010033}
}
EUVIMED